References
- Grant, S. M.; Heel, R. C. Vigabatrin. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Epilepsy and Disorders of Motor Control. Drugs. 1991, 41, 889–926. DOI: 10.2165/00003495-199141060-00007.
- Tae, W. K.; Paul, F. K.; Michael, B. S. Asymmetric Synthesis of (S)-4-Aminohex-5-Enoic Acid: A Potent Inhibitor of 4-Aminobutyrate-2-Oxoglutarate Aminotransferase. J. Org. Chem. 1992, 57, 6169–6173.
- Zhong-Yong, W.; Edward, E. K. A Short Efficient Synthesis of (S)-4-amino-5-hexenoic acid [(S)-vigabatrin]. J. Org. Chem 1993, 58, 1586–1588. DOI: 10.1021/jo00058a050.
- Wei, Z. Y.; Knaus, E. E. Asymmetric Synthesis of (S)-Vigabatrin. An Approach Using Methionine as the Chiral Pool. Synlett. 1993, 295–296. DOI: 10.1055/s-1993-22438.
- Wei, Z. Y.; Knaus, E. E. One-Step Reduction-Wittig Olefination of Methyl Pyroglutamate: Chiral Syntheses of (5S)-5-Alkenyl-2-Pyrrolidinones and (S)-Vigabatrin®. Synlett. 1994, 345–246. DOI: 10.1055/s-1994-22848.
- Zhong-Yong, W.; Edward, E. K. Asymmetric Synthesis of Both Enantiomers of Vigabatrin®: an Approach Using Methionine as the Chiral Pool. Tetrahedron 1994, 50, 5569–5578. DOI: 10.1016/S0040-4020(01)85629-5.
- Montserrat, A.; Marta, P.; Albert, M.; Miquel, A. P.; Antoni, R. Enantioselective Synthesis of (S)-Vigabatrin®. Tetrahedron Asymmetry. 1997, 8, 2967–2974. DOI: 10.1016/S0957-4166(97)00346-7.
- Alexandru, G.; Michael, S.; Oliver, R. Synthesis of Functionalized Pyrrolidin-2-Ones and (S)-Vigabatrin from Pyrrole. J. Org. Chem. 2006, 71, 2173–2176. DOI: 10.1021/jo0524472.
- Barry, M. T.; Remy, C. L. An Asymmetric Synthesis of Vigabatrin. Tetrahedron Lett 1996, 37, 9161–9164. DOI: 10.1016/S0040-4039(96)02148-X.
- Chandrasekhar, S.; Suchismita, M. Asymmetric Synthesis of anti-Convulsive Drug (S)-Vigabatrin®. Tetrahedron Lett 1998, 39, 6415–6418. DOI: 10.1016/S0040-4039(98)01324-0.
- Geraldine, M.; Walid, Z.; Pascale, C.; Sandrine, P.; Yannick, V. A Concise Formal Synthesis of (S)-Vigabatrin Based on Nitrone Umpolung. Synlett. 2003, 10, 1527–1529. DOI: 10.1055/s-2003-40824.
- Meng-Yang, C.; Chun-Yu, L.; Chi-Wi, O. Synthesis of Vigabatrin®. Heterocycles. 2006, 10, 2031–2036. DOI: 10.3987/COM-06-10837.
- Victor Paul Raj, I.; Sudalai, A. Asymmetric Synthesis of (S)-Vigabatrin® and (S)-Dihydrokavain via Cobalt Catalyzed Hydrolytic Kinetic Resolution of Epoxides. Tetrahedron Lett. 2008, 49, 2646–2648. DOI: 10.1016/j.tetlet.2008.02.064.
- Gnamm, C.; Franck, G.; Miller, N.; Stork, T.; Brodner, K.; Helmchen, G. Enantioselective Iridium-Catalyzed Allylic Aminations of Allylic Carbonates with Functionalized Side Chains. Asymmetric Total Synthesis of (S)-Vigabatrin. Synthesis. 2008, 3331–3350. DOI: 10.1055/s-0028-1083158.
- Margolin, A. L. Synthesis of Optically Pure Mechanism-Based Inhibitors of γ Aminobutyric Acid Aminotransferase (GABA-T) via Enzyme-Catalyzed Resolution. Tetrahedron Lett. 1993, 34, 1239–1242. DOI: 10.1016/S0040-4039(00)91763-5.
- Wei, Z. Y.; Edward, E. K. Resolution of 5-vinyl-2-pyrrolidinone. A practical synthesis of (s)- and (r)-vigabatrin. Org. Prep. Proced. Int. 1994, 26, 5. DOI: 10.1080/00304949409458058.
- Marie-Christine, D.; Bienayme, H.; Popowycz, F.; Lemaire, M. E. P. Patent. 2,537,827 A1, June 26, 2011.
- Jacek, G.; Krystyna, G. Tartaric and Malic Acids in Synthesis: A Source Book of Building Blocks, Ligands, Auxilliaries, and Resolving Agents; New York, USA: John Wiley & Sons, 1999.
- Xiao, Y.; Zhu, G.; Qi, W.; Zhou, Q.; Jiang, M.; Mei, Y.; Jin, W. A method for recovery of tartaric acid. Patent. CN105152911B, August 17, 2015.